What Meierbei.com does

Meierbei.com (美呗医美) is a Chengdu-headquartered, privately held medical aesthetics selection platform founded in 2011 by Gong Liansheng. The company operates as a two-sided marketplace that connects individual consumers seeking cosmetic procedures with 2,000+ partner medical institutions and 12,000+ licensed doctors across all 34 Chinese provinces, municipalities, and autonomous regions, with stated reach into overseas markets. The platform is positioned as a "high-end strict-selection" intermediary, using a 6-category, 26-item institutional review (less than 10% annual approval rate) and, since April 2021, a 6-dimension, 55-criteria "Mei Bei Diamond" tier (less than 1% acceptance rate) to curate supply. As of 2019, the platform had partnered with 39 of China's 51 nationally certified 5A medical aesthetic institutions, representing nearly 80% of that segment.

Underlying technology centers on an AI-driven recommendation and matching system layered with a machine-learning + human dual review mechanism for content authenticity and user privacy. The product surface includes a web portal (meb.com), iOS/Android mobile application, and a 350+ consultant workforce delivering 24/7 1-on-1 pre-, during-, and post-procedure consultation with up to 6 months of follow-up. Cumulative consultation volume has exceeded 80 million since founding.

Revenue is generated primarily through transaction/commission fees on consumer matches with partner institutions, supplemented by a premium membership tier offering priority consultation, special pricing, and enhanced after-sales concierge service. The company has raised approximately $18.8M in disclosed funding across rounds led by Cowin Capital (2015), Shenzhen Capital Group (2018), and Sichuan provincial government-affiliated investment funds (2019), with strategic partnerships including a 2020 alliance with hyaluronic acid manufacturer Bloomage Bio. Operational status is active, with no IPO or public listing disclosed.

Name

Meierbei.com

Legal name

成都美尔贝科技股份有限公司 (Chengdu Meierbei Technology Co., Ltd.)

Website

https://meierbei.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

101–250 employees

Short description

Meierbei.com is a Chengdu-based, privately held medical aesthetics selection platform founded in 2011 that connects individual Chinese consumers with 2,000+ vetted hospitals and 12,000+ licensed doctors via a curated, AI-assisted matching and 1-on-1 consultation model, generating revenue from platform commissions and premium memberships.

Ownership category

akta.pro rank

Headquarters

HQ city

Chengdu

HQ country

China

HQ region

Asia

Offices1 record

Markets served

GTM type

B2C

Offering type

Digital Commerce or Content

Cost components

Personnel, Marketing or Sales, Technology or R&D, Operations, Infrastructure

Revenue model

1. Platform Commission/Transaction Fee: As a medical aesthetics marketplace platform, Meierbei earns revenue by facilitating transactions between users and partner medical institutions. The platform connects users with 2000+ hospitals and 12,000+ doctors, earning commissions on successful matches and service completions.
2. Premium Membership Services: High-end membership services providing exclusive benefits including priority consultation, special pricing, and enhanced after-sales support. Premium members receive dedicated concierge services throughout their medical aesthetics journey.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

Meierbei.com is a high-end medical aesthetics selection platform that connects individual consumers with vetted partner hospitals and licensed doctors for cosmetic and plastic surgery procedures. The platform offers 1-on-1 pre-surgery, in-surgery, and post-surgery consultation services via 350+ professional aesthetics consultants, hospital/doctor matching, price comparison, customized treatment plans, authentic product verification, and after-sales follow-up.

Product overview

Meierbei.com operates as a unified medical beauty platform ecosystem consisting of three main products: the Meibei Medical Beauty Platform (美呗医美平台) as the core platform, the Meibei.com website (美呗网) as the web portal, and the Meibei mobile application (美呗APP) for on-the-go access. The platform functions as a medical aesthetic marketplace connecting users with over 2,000 partner hospitals and 12,000+ licensed doctors, offering services including 1-to-1 consultation, hospital selection, price comparison, and after-sales support across 34 provinces in China.

Differentiator

Problem solved

Functional benefit

Brands

• 美呗网 (Meibei Website): Online medical aesthetics consulting service platform offering hospital/doctor comparison, pricing comparison, customized plans, and authentic product recommendations.
• 美呗颜究院 (Meierbei Research Institute)
• 美呗APP
• 美呗美钻 (Meierbei Diamond)

Products and services

• Meibei Medical Beauty Platform (美呗医美平台) The core online platform that helps users answer plastic surgery questions, filter quality hospitals, compare facility prices, customize medical aesthetic plans, and select authentic medical beauty projects. It is the primary product of the company.
• Meibei.com Website (美呗网) The official web portal of the Meibei medical beauty platform, providing browser-based access to medical consultation, hospital matching, price comparison, and service booking for individual consumers.
• Meibei Mobile App (美呗APP)
• 1-on-1 Medical Aesthetics Consultation Service A personalized consultation service delivered by 350+ professional medical aesthetics consultants, available 24/7 year-round, covering pre-surgery Q&A, in-surgery support, and up to 6 months of post-procedure follow-up, targeted at individual medical aesthetics consumers.
• Premium Membership Services (高端会员尊享服务)
• Meibei Diamond Institution List (美呗美钻机构榜单) A premium curation/listing product launched in April 2021 that applies a 6-dimensional, 55-criteria evaluation framework with less than 1% acceptance rate to identify and rank top-tier medical aesthetics institutions for consumers.

Quantifiable outcome

• Nearly 80% of China's 5A medical aesthetics institutions are partnered with Meierbei (39 out of 51)
• +3 more outcomes

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Three partnerships are on record, tiered core.

• Hua Xi Bio (华熙生物)coreStrategic or Co-development Partner · 1 January 2020In 2020, Meierbei entered a strategic partnership with Hua Xi Bio, a leading hyaluronic acid manufacturer. The partnership focuses on product procurement, consumer demand analysis, and product design collaboration to ensure quality control and safety across all consumer touchpoints. This partnership supports Meierbei's 'Strict Selection of Authentic Products' initiative.
• Partner Medical Institutions (2000+)coreChannel Partner/ Reseller/ DistributorMeierbei partners with 2000+ compliant medical institutions across 34 provinces. All partner institutions must pass the 6-dimension, 26-criteria review with less than 10% annual approval rate. Nearly 80% of China's 5A medical aesthetics institutions (39 of 51) are partnered with Meierbei.
• Partner Doctors (12000+)coreChannel Partner/ Reseller/ DistributorMeierbei collaborates with 12,000+ qualified doctors who possess valid medical practitioner certificates (医师执业证 and 医师资格证). Foreign doctors must also hold the Foreign Doctor Short-term Practice Permit. Anesthesiologists are also required to have proper certifications.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• SoYoung International (新氧): NASDAQ-listed Chinese medical aesthetics internet platform that facilitates user discovery of cosmetic treatment providers, doctor reviews, and bookings. Directly competes with Meierbei as the other major player in China's medical aesthetics marketplace space, serving the same consumer and institutional customers with a similar content-plus-matching model.
• Gengmei (更美): Chinese medical aesthetics platform offering hospital discovery, doctor matching, and booking services. Competes head-on with Meierbei in the same domestic segment, targeting consumer demand for cosmetic procedure selection and comparison.
• RealSelf: US-based medical aesthetics platform providing doctor/institution discovery, reviews, and consumer education for cosmetic procedures. Operates a comparable content-led, trust-driven marketplace model targeting the same medical aesthetics consumer use case in a different geography.

Broad incumbents

• Alma Lasers: Global manufacturer of medical and aesthetic laser, light, and ultrasound devices used by clinics and medical aesthetic institutions. Operates upstream in the same value chain Meierbei intermediates, with reach into the same institutional clients.
• AbbVie / Allergan Aesthetics: Global aesthetics pharmaceutical leader (Botox, fillers, skincare) supplying products consumed in aesthetic procedures. Adjacent to Meierbei's selective product supply chain and the institutions transacted on its platform.
• Alibaba Health (阿里健康): Major Chinese digital health and pharmaceutical e-commerce platform operated by Alibaba. Overlaps with Meierbei in digitizing healthcare consumer journeys and could enter medical aesthetics matchmaking as part of its broader healthcare marketplace.

Emerging players

• Zwivel: Online consultation and matching platform that connects consumers with cosmetic doctors for virtual consultations and treatment planning. Overlaps with Meierbei's 1-on-1 pre-surgery consultation role, though focused on the US market and an earlier-stage offering.

Others

• Bloomage Bio (华熙生物): Leading Chinese hyaluronic acid manufacturer and an existing strategic partner of Meierbei (product procurement, demand analysis, design collaboration). Enables Meierbei's authentic-product selection pillar and represents an upstream supply relationship in the same industry value chain.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds3 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Meierbei.com